Recombinant host cell with altered membrane lipid composition

US11479798B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11479798-B2
Application numberUS-201816499072-A
CountryUS
Kind codeB2
Filing dateMar 28, 2018
Priority dateMar 29, 2017
Publication dateOct 25, 2022
Grant dateOct 25, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of expressing a protein of interest (POI) from a host cell. The invention relates particularly to improving a host cell's capacity to express and/or secrete a protein of interest and use of the host cell for protein expression. The invention also relates to cell culture technology, and more specifically to culturing cells to produce desired molecules for medical purposes or food products.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of increasing the yield of a protein of interest in a eukaryotic host cell, comprising overexpressing in said host cell at least one polynucleotide encoding at least one protein which is involved in lipid metabolism, thereby increasing the yield of said protein of interest in comparison to a host cell which does not overexpress a polynucleotide encoding a protein which is involved in lipid metabolism, wherein said protein which is involved in lipid metabolism is involved in sphingolipid biosynthesis and comprises an amino acid sequence as shown in SEQ ID NO: 1 or a homologue thereof having at least 70% sequence identity to an amino acid sequence as shown in SEQ ID NO: 1. 2. A method of manufacturing a protein of interest according to claim 1 comprising: providing the host cell engineered to overexpress at least one polynucleotide encoding at least one protein, wherein said protein which is involved in lipid metabolism is involved in sphingolipid biosynthesis and comprises an amino acid sequence as shown in SEQ ID NO: 1 or a homologue thereof, wherein the homologue has at least 70% sequence identity to an amino acid sequence as shown in SEQ ID NO: 1, wherein said host cell comprises a heterologous polynucleotide encoding a protein of interest; culturing the host cell under suitable conditions to overexpress the protein involved in lipid metabolism or homologue thereof and to express said protein of interest; and optionally isolating said protein of interest from the cell culture. 3. A recombinant eukaryotic host cell for manufacturing a protein of interest, wherein the host cell is engineered to overexpress at least one polynucleotide encoding at least one protein which is involved in lipid metabolism, wherein said protein which is involved in lipid metabolism is involved in sphingolipid biosynthesis and comprises an amino acid sequence as shown in SEQ ID NO: 1 or a homologue thereof, wherein the homologue has at least 70% sequence identity to an amino acid sequence as shown in SEQ ID NO: 1. 4. The method of claim 1 , wherein the host cell is selected from the group consisting of Pichia pastoris, Hansenula polymorpha, Trichoderma reesei, Saccharomyces cerevisiae, Kluyveromyces lactis, Yarrowia lipolytica, Pichia methanolica, Candida boidinii, Komagataella sp., Aspergillus sp. and Schizosaccharomyces pombe. 5. The method of claim 2 , wherein the host cell is selected from the group consisting of Pichia pastoris, Hansenula polymorpha, Trichoderma reesei, Saccharomyces cerevisiae, Kluyveromyces lactis, Yarrowia lipolytica, Pichia methanolica, Candida boidinii, Komagataella sp., Aspergillus sp. and Schizosaccharomyces pombe. 6. The recombinant eukaryotic host cell of claim 3 , wherein the host cell is selected from the group consisting of Pichia pastoris, Hansenula polymorpha, Trichoderma reesei, Saccharomyces cerevisiae, Kluyveromyces lactis, Yarrowia lipolytica, Pichia methanolica, Candida boidinii, Komagataella sp., Aspergillus sp. and Schizosaccharomyces pombe.

Assignees

Inventors

Classifications

  • C12P21/02Primary

    having a known sequence of two or more amino acids, e.g. glutathione · CPC title

  • C12N15/67Primary

    General methods for enhancing the expression · CPC title

  • for yeasts other than Saccharomyces · CPC title

  • C12N15/63Primary

    Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression · CPC title

  • Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11479798B2 cover?
The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of expressing a protein of interest (POI) from a host cell. The invention relates particularly to improving a host cell's capacity to express and/or secrete a protein of interest and use of the host cell for protein expression. The inv…
Who is the assignee on this patent?
Boehringer Ingelheim Rcv Gmbh, Validogen Gmbh, Lonza Ag, and 2 more
What technology area does this patent fall under?
Primary CPC classification C12P21/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).